Drug
Bmn 110
Bmn 110: highest development phase Phase 3, developed by BioMarin Pharmaceutical. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- BioMarin Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| BMN 110 NCT01966029 | Phase 3 | Mucopolysaccharidosis IVA (Morquio A Syndrome) |
| BMN 110 NCT01609062 | Phase 2 | Mucopolysaccharidosis IVA |
| BMN 110 NCT01242111 | Phase 1/2 | MPS IV A |
Latest
No recent events.
Follow Bmn 110 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.